Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.464
-0.028 (-5.63%)
At close: Nov 4, 2024, 4:00 PM
0.465
+0.001 (0.22%)
Pre-market: Nov 5, 2024, 4:51 AM EST
Enveric Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -10.59 | -17.29 | -18.47 | -48.98 | -6.86 | -2.41 | |
| Depreciation & Amortization | 0.35 | 0.41 | 0.44 | 0.68 | 0.12 | - | |
| Other Amortization | - | - | - | - | 0.29 | 0.07 | |
| Loss (Gain) From Sale of Assets | 0 | -0 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 7.45 | 38.68 | - | - | |
| Stock-Based Compensation | 1.46 | 2.15 | 2.62 | 12.63 | 1.98 | 0.62 | |
| Other Operating Activities | 0.36 | 0.82 | -8.97 | -15.66 | 0.96 | 0.05 | |
| Change in Accounts Payable | -2.1 | -0.1 | 0.26 | 0.38 | 0.27 | 0.92 | |
| Change in Other Net Operating Assets | 0.55 | -0.07 | -0.48 | 0.8 | -0.64 | 0.1 | |
| Operating Cash Flow | -9.98 | -14.09 | -17.15 | -11.46 | -3.89 | -0.65 | |
| Capital Expenditures | 0 | -0.01 | -0.58 | -0.19 | - | - | |
| Sale of Property, Plant & Equipment | -0 | 0.02 | - | - | - | - | |
| Cash Acquisitions | - | - | - | 3.06 | - | - | |
| Sale (Purchase) of Intangibles | - | - | - | -0.68 | -0.04 | - | |
| Investing Cash Flow | -0 | 0.01 | -0.58 | 2.19 | -0.04 | - | |
| Short-Term Debt Issued | - | - | - | - | 1.86 | 0.56 | |
| Total Debt Issued | - | - | - | - | 1.86 | 0.56 | |
| Short-Term Debt Repaid | - | - | - | - | -0.19 | - | |
| Total Debt Repaid | - | - | - | - | -0.19 | - | |
| Net Debt Issued (Repaid) | - | - | - | - | 1.67 | 0.56 | |
| Issuance of Common Stock | 5.05 | - | 17.22 | 24.9 | 3.86 | - | |
| Other Financing Activities | 0.3 | -1.34 | 0.96 | - | - | - | |
| Financing Cash Flow | 6.4 | -1.34 | 18.18 | 24.9 | 5.53 | 0.56 | |
| Foreign Exchange Rate Adjustments | -0 | -0.01 | -0.08 | 0.14 | -0.06 | 0.02 | |
| Net Cash Flow | -3.58 | -15.44 | 0.37 | 15.78 | 1.53 | -0.07 | |
| Free Cash Flow | -9.98 | -14.1 | -17.73 | -11.65 | -3.89 | -0.65 | |
| Free Cash Flow Per Share | -2.49 | -6.53 | -12.26 | -24.66 | -33.79 | -6.13 | |
| Cash Interest Paid | - | - | 0.01 | 0.01 | - | - | |
| Cash Income Tax Paid | 0.03 | 0.01 | - | - | - | - | |
| Levered Free Cash Flow | -9.04 | -9.9 | -8.38 | -1.75 | -2.58 | 0.14 | |
| Unlevered Free Cash Flow | -9.04 | -9.9 | -8.38 | -1.75 | -2.59 | 0.12 | |
| Change in Net Working Capital | 4.47 | 2.17 | -1.63 | -1.61 | 1.13 | -0.94 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.